| ABs | Antibiotics |
| AMR | Antimicrobial resistance |
| ARG | Antibiotic resistant genes |
| ATP | Adenosine triphosphate |
| CRHP | Clarithromycin-resistant H. pylori |
| CRNG | Cephalosporin-resistant N. gonorrhoeae |
| EOs | Essential oils |
| ESBL | Extended spectrum beta-lactamase |
| ESKAPE | E. faecium, S. aureus, K. pneumoniae, A. baumanni, P. aeruginosa and E. cloacae |
| EU | European Union |
| FIC | Fractional inhibitory concentration |
| FRNG | Fluoroquinolone-resistant N. gonorrhoeae |
| FRS | Fluoroquinolone-resistant Salmonellae spp. |
| GLASS | Global Antimicrobial Resistance Surveillance System |
| HPP | High priority pathogen |
| IC50 | Half-maximal inhibitory concentration |
| iNTS | Invasive nontyphoidal salmonellosis |
| KPC | K. Pneumoniae carbapenemase |
| MBC | Minimum bactericidal concentration |
| MBEC50% | Minimum biofilm inhibitory concentration |
| MDR | Multidrug resistant |
| MIC | Minimum inhibitory concentration |
| MRSA | Methicillin-resistant Staphylococcus aureus |
| MSSA | Methicillin-sensitive Staphylococcus aureus |
| niNTS | Non-invasive non-typhoidal salmonellosis |
| NTS | Nontyphoidal salmonellosis |
| PDR | Pandrug-resistant |
| PMQR | Plasmid-mediated quinolone resistance |
| PPI | Proton-pump inhibitor |
| RNA | Ribonucleic acid |
| QRDR | Quinolone resistance-determining region |
| VISA | Vancomycin-intermediate Staphylococcus aureus |
| VREF | Vancomycin-resistant Enterococcus faecium |
| VSEF | Vancomycin-sensitive Enterococcus faecium |
| VRSA | Vancomycin-resistant S. aureus |
| WHO | World Health Organization |
| XDR | Extensively drug-resistant |
| ZOI | Zone of inhibition |